| 
June 15, 2006
SPECIALTY DRUG COSTS SOAR, ESRX SAYS
Expenditures on biotech drugs to treat inflammatory diseases—including Enbrel (Amgen), Humira (Abbott Labs), Kineret (Amgen) and Remicade (Centocor)—increased 34% in 2005, according to the 2006 Express Scripts Drug Trend Report.
Subscribers: Click Here for the Full Story
Non-Subscribers: Click Here to Subscribe
Pay Per View ($75.00)
|
